Association of LMNA 1908C/T polymorphism with cerebral vascular disease and diabetic nephropathy in Japanese men with type 2 diabetes

Clinical Endocrinology

Volumn 63, Issue 3, 2005, Pages 317-322

  Liang, Hua ^a,b   Murase, Yuko ^a   Katuta, Yuko ^a   Asano, Akimichi ^a   Kobayashi, Junji ^a   Mabuchi, Hiroshi ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DNA POLYMORPHISM; ECHOGRAPHY; ELECTROCARDIOGRAPHY; GENE LOCUS; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; JAPAN; LMNA GENE; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; CEREBROVASCULAR DISORDERS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LAMIN TYPE A; LAMINS; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; STATISTICS, NONPARAMETRIC;

EID: 24144462222     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2005.02344.x     Document Type: Article

References (30)

1. DeFronzo, R.A. & Ferrannini, E. (1991) Insulin resistance. A multi-faceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care, 14, 173-194.
2. Stamler, J., Vaccaro, O., Neaton, J.D. & Wentworth, D. (1993) Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care, 16, 434-444.
3. Forsblom, C.M., Kanninen, T., Lehtovirta, M., Saloranta, C. & Groop, L.C. (1999) Heritability of albumin excretion rate in families of patients with type II diabetes. Diabetologia, 42, 1359-1366.
4. Nelson, R.G., Wolfe, J.A. & Horton, M.B. (1989) Proliferative retinopathy in NIDDM. Incidence and risk factors in Pima Indians. Diabetes, 38, 435-440.
5. Cao, H. & Hegele, R.A. (2000) Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy. Human Molecular Genetics, 9, 109-112.
6. Flier, J.S. (2000) Pushing the envelope on lipodystrophy. Nature Genetics, 24, 103-104.
7. Hegele, R.A. (2001) Premature atherosclerosis associated with monogenic insulin resistance. Circulation, 103, 2225-2229.
8. Hegele, R.A., Anderson, C.M., Wang, J., Jones, D.C. & Cao, H. (2000) Association between nuclear lamin A/C R482Q mutation and partial lipodystrophy with hyperinsulinemia, dyslipidemia, hypertension, and diabetes. Genome Research, 10, 652-658.
9. Lin, F. & Worman, H.J. (1993) Structural organization of the human gene encoding nuclear lamin A and nuclear lamin C. Journal of Biological Chemistry, 268, 16321-16326.
10. Steinle, N.I., Kazlauskaitem, R., Imumorin, I.G., Hsueh, W.C., Pollin, T.I., O'Connell, J.R., Mitchell, B.D. & Shuldiner, A.R. (2004) Variation in the lamin A/C gene: associations with metabolic syndrome. Arteriosclerosis, Thrombosis and Vascular Biology, 24, 1708-1713.
11. Hegele, R.A., Cao, H., Harris, S.B., Zinman, B., Hanley, A.J. & Anderson, C.M. (2000) Genetic variation in LMNA modulates plasma leptin and indices of obesity in aboriginal Canadians. Physiological Genomics, 3, 39-44.
12. Weyer, C., Wolford, J.K., Hanson, R.L., Foley, J.E., Tataranni, P.A., Bogardus, C. & Pratley, R.E. (2001) Subcutaneous abdominal adipocyte size, a predictor of type 2 diabetes, is linked to chromosome 1q21-q23 and is associated with a common polymorphism in LMNA in Pima Indians. Molecular Genetics and Metabolism, 72, 231-238.
13. Hegele, R.A., Huff, M.W. & Young, T.K. (2001) Common genomic variation in LMNA modulates indexes of obesity in Inuit. Journal of Clinical Endocrinology and Metabolism, 86, 2747-2751.
14. Murase, Y., Yagi, K., Katsuda, Y., Asano, A., Koizumi, J. & Mabuchi, H. (2002) An LMNA variant is associated with dyslipidemia and insulin resistance in the Japanese. Metabolism, 51, 1017-1021.
15. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, 20, 1183-1197.
16. National Institute of Neurological Disorders and Stroke (1990) Special report from the National Institute of Neurological Disorders and Stroke: classification of cerebrovascular disease III. Stroke, 21, 637-676.
17. Adams, H.P. Jr, Bendixen, B.H., Kappelle, L.J., Biller, J., Love, B.B. & Gordon, D.L. (1993) Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial: TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke, 24, 35-41.
18. Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., Kuriyama, H., Nishida, M., Yamashita, S., Okubo, K., Matsubara, K., Muraguchi, M., Ohmoto, Y., Funahashi, T. & Matsuzawa, Y. (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochemical and Biophysical Research Communications, 257, 79-83.
19. Sahadevan, M. & Kasiske, B.L. (2002) Hyperlipidemia in kidney disease: causes and consequences. Current Opinion in Nephrology and Hypertension, 11, 323-329.
20. Crook, E.D., Thallapureddy, A., Migdal, S., Flack, J.M., Greene, E.L., Salahudeen, A., Tucker, J.K. & Taylor, H.A. Jr (2003) Lipid abnormalities and renal disease: is dyslipidemia a predictor of progression of renal disease? American Journal of Medical Science, 325, 340-348.
21. Iprinsen, B.H., de Sain-van der Velden, M.G., de Koning, E.J., Koomans, H.A., Berger, R. & Rabelink, T.J. (2003) Hypertriglyceridemia in patients with chronic renal failure: possible mechanisms. Kidney International Supplement, 84, S121-S124.
22. Grone, E.F., Walli, A.K., Grone, H.J., Miller, B. & Seidel, D. (1994) The role of lipids in nephrosclerosis and glomerulosclerosis. Atherosclerosis, 107, 1-13.
23. Grone, H.J., Hohbach, J. & Grone, E.F. (1996) Modulation of glomerular sclerosis and interstitial fibrosis by native and modified lipoproteins. Kidney International Supplement, 54, S18-S22.
24. Tolins, J.P., Stone, B.C. & Raij, L. (1992) Interactions of hypercholesterolemia and hypertension in initiation of glomerular injury. Kidney International, 41, 1254-1261.
25. Nakayama, T., Date, C., Yokoyama, T., Yoshiike, N., Yamaguchi, M. & Tanaka, H. (1997) A 15.5-year follow-up study of stroke in a Japanese provincial city. The Shibata Study. Stroke, 28, 45-52.
26. Laloux, P., Galanti, L. & Jamart, J. (2004) Lipids in ischemic stroke subtypes. Acta Neurologica Belgica, 104, 13-19.
27. Lindgren, A., Nilsson-Ehle, P., Norrving, B. & Johansson, B.B. (1992) Plasma lipids and lipoproteins in subtypes of stroke. Acta Neurologica Scandinavica, 86, 572-578.
28. Eastern Stroke and Coronary Heart Disease Collaborative Research Group (1998) Blood pressure, cholesterol, and stroke in eastern Asia. Lancet, 352, 1801-1807.
29. Qizilbash, N., Lewington, S., Duffy, S., Peto, R., Smith, T. & Spiegelhalter, D. (1995) Cholesterol, diastolic blood pressure, and stroke: 13 000 strokes in 450 000 people in 45 prospective cohorts. Prospective studies collaboration. Lancet, 346, 1647-1653.
30. Mailloux, L.U. (2001) Hypertension in chronic renal failure and ESRD: prevalence, pathophysiology, and outcomes. Seminars in Nephrology, 21, 146-156.